Actionable news
0
All posts from Actionable news
Actionable news in TEVA: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES,

Teva Stock Gains, Leerink: Despite Patent Loss, No Generic Competition Until 2018

NEW YORK (TheStreet) -- Teva Pharmaceuticals (TEVA) stock was up in mid-morning trading on Thursday as Leerink said in a note this morning that generic challengers to its multiple sclerosis drug, Copaxone, will be kept off the market until 2018.

Yesterday, the U.S. Patent Office's Patent Trial and Appeal Board deemed that two of Teva's Copaxone patents are considered unpatentable. The office will rule on the Israel-based pharmaceutical company's remaining patents on the drug in upcoming weeks.

Rival drug maker Mylan (MYL) has filed with the FDA to unveil...


More